Australia Stock Exchange release from NEUROSCIENTIFIC : Successful completion of pivotal ocular safety study
Australia Stock Exchange release from NEUROSCIENTIFIC NSB.AX : Successful completion of pivotal ocular safety study
Recent news on Neuroscientific Biopharmaceuticals
See all newsBrief: Neuroscientific Biopharmaceuticals Appoints Chris Knee As CFO
Brief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results
Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO